Investors are more concerned over the next phase of the industry cycle and the impact it will have on Premier’s profit ...

NDA for treatment of sBCC with Ameluz®-PDT submitted to U.S. Food and Drug Administration (FDA) on November 28, 2025First ...

Prospective-trial analysis published in the Journal of the National Cancer Institute predicts residual cancer burden from ...

When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication ...

Biomarker-activated cancer drug-candidate LP-184 demonstrates encouraging efficacy signals in DNA damage repair deficient ...

When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication process can cause alterations in genomic DNA, promoting cellular ageing, cancer, ...

Orano Med, a subsidiary of the Orano group specializing in nuclear medicine, announced today that its long-standing collaboration with the multinational pharmaceutical company Roche (SIX: RO, ROG; ...

(“DIMERx”), a clinical-stage biopharmaceutical company developing first-in-class dimer-based therapeutics for major public-health needs, today announced the appointment of Lee S. Simon, MD, former ...

New studies reveal the brain's shifting architecture at different ages, breastfeeding-driven cancer immunity, and a cosmic ...

New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.

The Sun has recently produced two colossal X-class solar flares that disrupted radio signals across large swaths of the globe ...

When cells proliferate, genomic DNA is precisely duplicated once per cell cycle. Abnormalities in this DNA replication ...